Grunenthal SA
28.8 FTEThe score of Grunenthal shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +73 % Equity -20 % Total assets +21 % Headcount (avg FTE) +29 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Grunenthal's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
Grunenthal's financial analysis
- Solvency31.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Grunenthal
Grunenthal's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.085.874
- VAT number
- BE0403085874
- Peppol
- Registered · 0208:0403085874 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 12 Oct 1966
- Registered office
- 1932 Zaventem
- Size
- Small · 28.8 FTE
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Grunenthal (SA) has been based in Zaventem since 1966, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €39.3m, a net profit of €2.22m and equity of €5.12m. With 28.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 31.6%, below the median of its sector (46.0%).
Companies similar to Grunenthal
Companies in the same business, of comparable size and area, outside its group.
- Biotronik Belgium Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €22.1m
- B. Braun Medical Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €22.6m
- Straumann Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €10.5m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
- Livanova Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €38.8m
- Canon Medical Systems Belgium Manufacture of medical and dental instruments and supplies Zaventem · balance sheet €9.24m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Ortho - Clinical Diagnostics Manufacture of medical and dental instruments and supplies Zaventem · balance sheet €17.3m
Frequently asked questions about Grunenthal
What is the revenue of Grunenthal?
According to the 2025 annual accounts filed with the NBB, the revenue of Grunenthal amounts to 39,276,527 €.
What is the VAT number of Grunenthal?
In Belgium, the VAT number is the company number prefixed with BE: BE0403085874 for Grunenthal, if the company is VAT-registered. Its company number (CBE) is 0403.085.874.
Where is the registered office of Grunenthal?
According to the CBE register, the registered office of Grunenthal is in 1932 Zaventem.
What is the equity of Grunenthal?
At the close of the 2025 financial year, the equity of Grunenthal amounts to 5,122,762 €, a solvency of 31.6% of total assets.
How many people work at Grunenthal?
28.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Grunenthal?
The register lists 5 active mandates at Grunenthal. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Grunenthal
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →